Author:
Wilczak Waldemar,Wittmer Corinna,Clauditz Till,Minner Sarah,Steurer Stefan,Büscheck Franziska,Krech Till,Lennartz Maximilian,Harms Luisa,Leleu Diane,Ahrens Marc,Ingwerth Sebastian,Günther Christian T.,Koop Christina,Simon Ronald,Jacobsen Frank,Tsourlakis Maria C.,Chirico Viktoria,Höflmayer Doris,Vettorazzi Eik,Haese Alexander,Steuber Thomas,Salomon Georg,Michl Uwe,Budäus Lars,Tilki Derya,Thederan Imke,Fraune Christoph,Göbel Cosima,Henrich Marie-Christine,Juhnke Manuela,Möller Katharina,Bawahab Ahmed Abdullah,Uhlig Ria,Adam Meike,Weidemann Sören,Beyer Burkhard,Huland Hartwig,Graefen Markus,Sauter Guido,Schlomm Thorsten
Reference35 articles.
1. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Senkus;Ann Oncol,2015
2. Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline;Harris;J Oncol Pract,2016
3. Adjuvant therapy for stage I and II non-small cell lung cancer;Naylor;Surg Oncol Clin N Am,2016
4. Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer;Pirker;Transl Lung Cancer Res,2014
5. Cost-effectiveness of adjuvant chemotherapy in the treatment of early-stage colon cancer;Soni;Clin Colorectal Cancer,2015